Bonnes pratiques de fabrication actuelles (BPF)

Current Bonnes pratiques de fabrication (cGMP) refers to the regulations enforced by the Food and Drug Administration (FDA) that ensure the quality and safety of pharmaceutical and biotechnology products through systematic processes. These practices encompass all aspects of production, including design, monitoring, and control, to ensure that products are consistently produced and controlled according to established quality standards. Adherence to cGMP is essential for minimizing risks involved in pharmaceutical production and ensuring that products are safe for consumer use.